Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul M. Ridker, M.D.

Co-Author

This page shows the publications co-authored by Paul Ridker and Meir Stampfer.
Connection Strength

2.322
  1. Assessment of genetic markers for coronary thrombosis: promise and precaution. Lancet. 1999 Feb 27; 353(9154):687-8.
    View in: PubMed
    Score: 0.213
  2. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997 Apr 01; 95(7):1777-82.
    View in: PubMed
    Score: 0.187
  3. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994 Nov; 90(5):2236-40.
    View in: PubMed
    Score: 0.158
  4. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA. 1993 Nov 10; 270(18):2195-9.
    View in: PubMed
    Score: 0.148
  5. Risk factor criteria. Circulation. 2004 Jun 29; 109(25 Suppl 1):IV3-5.
    View in: PubMed
    Score: 0.077
  6. A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men. Atherosclerosis. 2003 Feb; 166(2):323-9.
    View in: PubMed
    Score: 0.070
  7. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002 Jun 04; 105(22):2595-9.
    View in: PubMed
    Score: 0.067
  8. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002 Mar; 75(3):492-8.
    View in: PubMed
    Score: 0.066
  9. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med. 2001 Aug 07; 135(3):184-8.
    View in: PubMed
    Score: 0.063
  10. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 May 16; 285(19):2481-5.
    View in: PubMed
    Score: 0.062
  11. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000 Apr 18; 101(15):1767-72.
    View in: PubMed
    Score: 0.058
  12. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol. 1999 Apr; 33(5):1347-52.
    View in: PubMed
    Score: 0.054
  13. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 1999 Mar 09; 99(9):1161-4.
    View in: PubMed
    Score: 0.053
  14. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998 Dec 22-29; 98(25):2796-9.
    View in: PubMed
    Score: 0.052
  15. Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study. J Cardiovasc Risk. 1998 Aug; 5(4):273-8.
    View in: PubMed
    Score: 0.051
  16. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998 Feb 10; 97(5):425-8.
    View in: PubMed
    Score: 0.050
  17. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998 Jan 10; 351(9096):88-92.
    View in: PubMed
    Score: 0.049
  18. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol. 1997 Sep; 17(9):1687-90.
    View in: PubMed
    Score: 0.048
  19. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet. 2017 Jun; 49(6):834-841.
    View in: PubMed
    Score: 0.047
  20. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr 03; 336(14):973-9.
    View in: PubMed
    Score: 0.047
  21. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med. 1997 Apr 01; 126(7):528-31.
    View in: PubMed
    Score: 0.047
  22. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 1997 Feb 08; 349(9049):385-8.
    View in: PubMed
    Score: 0.046
  23. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation. 1997 Jan 07; 95(1):59-62.
    View in: PubMed
    Score: 0.046
  24. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation. 1995 Nov 15; 92(10):2800-2.
    View in: PubMed
    Score: 0.042
  25. Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA. 1995 Apr 26; 273(16):1269-73.
    View in: PubMed
    Score: 0.041
  26. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995 Apr 06; 332(14):912-7.
    View in: PubMed
    Score: 0.041
  27. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994 Sep 28; 272(12):929-33.
    View in: PubMed
    Score: 0.039
  28. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature. 2014 Oct 02; 514(7520):92-97.
    View in: PubMed
    Score: 0.039
  29. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet. 1994 Apr 16; 343(8903):940-3.
    View in: PubMed
    Score: 0.038
  30. A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100. Arterioscler Thromb. 1993 Nov; 13(11):1587-92.
    View in: PubMed
    Score: 0.037
  31. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993 May 08; 341(8854):1165-8.
    View in: PubMed
    Score: 0.036
  32. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Circulation. 1992 May; 85(5):1822-7.
    View in: PubMed
    Score: 0.033
  33. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism. 2008 Mar; 57(3):437-43.
    View in: PubMed
    Score: 0.025
  34. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia. 2008 Feb; 51(2):267-75.
    View in: PubMed
    Score: 0.024
  35. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007; 22(12):839-69.
    View in: PubMed
    Score: 0.024
  36. Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years. Am J Cardiol. 2005 Jul 01; 96(1):83-8.
    View in: PubMed
    Score: 0.021
  37. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clin Chem. 2004 Aug; 50(8):1364-71.
    View in: PubMed
    Score: 0.019
  38. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002 Apr 11; 346(15):1113-8.
    View in: PubMed
    Score: 0.017
  39. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis. 2002 Apr; 161(2):469-74.
    View in: PubMed
    Score: 0.017
  40. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001 Feb 22; 344(8):549-55.
    View in: PubMed
    Score: 0.015
  41. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation. 1999 Oct 19; 100(16):1722-6.
    View in: PubMed
    Score: 0.014
  42. Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation. 1999 Jan 26; 99(3):340-3.
    View in: PubMed
    Score: 0.013
  43. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996 May 02; 334(18):1145-9.
    View in: PubMed
    Score: 0.011
  44. Discrimination in absorption or transport of beta-carotene isomers after oral supplementation with either all-trans- or 9-cis-beta-carotene. Am J Clin Nutr. 1995 Jun; 61(6):1248-52.
    View in: PubMed
    Score: 0.010
  45. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med. 1990 Dec; 89(6):772-6.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.